In plain words

Of four trials, two in men found testosterone rose more with ashwagandha than with a placebo. One measured it in saliva and the other measured free testosterone in blood. The other two found no difference from placebo, and one of those studied women around menopause. The second trial in men also found no difference in total testosterone.

The short answer

Two of four randomized trials found a rise against placebo; two did not. In 40 overweight men, 600 mg a day for 8 weeks was associated with a 14.7% greater rise in saliva testosterone (Lopresti, 2019). In 56 people on 400 mg a day for 12 weeks, men's free testosterone rose but total did not differ (Smith, 2023). Gopal (2021) found 300 mg twice a day for 8 weeks was not associated with a difference in 100 perimenopausal women. A second Lopresti trial (2019) found no difference against placebo; the ledger has no n, dose or duration for it. Certainty is low, because the trials measured different kinds of testosterone.

The 60-second version

Every study in the video is listed below, with its quote.

Watch on YouTube

Where the evidence sits

Rose more than placebo

■ Randomized trial, Lopresti et al., 2019 · 40 people · 8 weeks
■ Randomized trial, Smith et al., 2023 · 56 people · 12 weeks · total testosterone no different
□ Review, Gómez Afonso A et al., 2023 · summarises other studies
□ Review, NCCIH (NIH), 2023 · summarises other studies

No difference from placebo

■ Randomized trial, Lopresti et al., 2019 · ledger has no n
■ Randomized trial, Gopal et al., 2021 · 100 people · 8 weeks

■ measured by the source's own study · ◪ pooled analysis, may overlap studies counted here · □ reported, reviewed or argued, no new data

Evidence weight5757 / 100?

Who says what

SourceFindingDesignPeopleDose and lengthFunding and independence
Lopresti, 2019, men14.7% greater saliva riseRandomized crossover40 overweight men600 mg daily, 8 weeksNot in ledger
Smith, 2023Free rose; total unchangedRandomized, placebo56200 mg twice daily, 12 weeksNot in ledger
Lopresti, 2019, MedicineNot against placeboRandomized, placeboBoth sexesNot in ledgerNot in ledger
Gopal, 2021No differenceRandomized, placebo100 perimenopausal women300 mg twice daily, 8 weeksNot in ledger
Gómez Afonso, 2023Two studies reported risesReview of studiesNot in ledgerNot in ledgerNot in ledger
NCCIH, 2023Possible riseAgency summary of studiesNot in ledger2 to 4 monthsUS NIH
Lopresti, 2019, men

14.7% greater saliva rise

Design
Randomized crossover
People
40 overweight men
Dose and length
600 mg daily, 8 weeks
Funding
Not in ledger
Smith, 2023

Free rose; total unchanged

Design
Randomized, placebo
People
56
Dose and length
200 mg twice daily, 12 weeks
Funding
Not in ledger
Lopresti, 2019, Medicine

Not against placebo

Design
Randomized, placebo
People
Both sexes
Dose and length
Not in ledger
Funding
Not in ledger
Gopal, 2021

No difference

Design
Randomized, placebo
People
100 perimenopausal women
Dose and length
300 mg twice daily, 8 weeks
Funding
Not in ledger
Gómez Afonso, 2023

Two studies reported rises

Design
Review of studies
People
Not in ledger
Dose and length
Not in ledger
Funding
Not in ledger
NCCIH, 2023

Possible rise

Design
Agency summary of studies
People
Not in ledger
Dose and length
2 to 4 months
Funding
US NIH

Did men's testosterone rise more than with placebo?

In Lopresti and colleagues' crossover trial (2019), 40 overweight men aged 40 to 70 with mild fatigue took 600 mg a day and a placebo for 8 weeks each, with saliva testosterone measured:

14.7% greater increase in testosterone (p = .010) compared to the placebo

Smith and colleagues (2023) gave 56 people 200 mg twice a day or a placebo for 12 weeks:

In the men taking ashwagandha, there was a significant increase in the blood concentrations of free testosterone (p = 0.048)

Smith's paper reports no group difference in total testosterone.

Did it beat placebo, or only the starting level?

A second Lopresti trial (2019, Medicine) compared people with their starting levels and with placebo; the ledger has no n, dose or duration for it:

Testosterone levels increased in males ( P = .038) but not females ( P = .989) over time, although this change was not statistically significant compared with the placebo ( P = .158).

Gopal and colleagues (2021) gave 100 perimenopausal women 300 mg twice a day or a placebo for 8 weeks:

There was no significant between the group differences in the serum testosterone level.

What do the reviews say?

Gómez Afonso and colleagues (2023) reviewed published studies that may include the trials above, so it adds no measurement; the ledger has no n or dose for them:

Two studies reported significant increases in testosterone levels in the Ashwagandha intervention group relative to the control [15, 39].

NCCIH, part of the US National Institutes of Health, summarized others' studies in 2023, with no n or dose in the ledger:

There is some limited evidence that suggests that taking ashwagandha for 2 to 4 months may increase testosterone levels and sperm quality.

Why the sources disagree

The comparison differs: in the Medicine trial, men's testosterone rose against starting levels but not against placebo, and NCCIH's comparison is not in the ledger. The measure differs: saliva testosterone in the crossover trial, free and total blood testosterone in Smith's, serum testosterone in Gopal's. The people differ, from overweight men to perimenopausal women. Trials with n in the ledger (40 to 100 people) gave 400 to 600 mg a day for 8 to 12 weeks. No trial's funding source is in the ledger.

What would settle it

A preregistered, placebo-controlled trial in several hundred men, run by a group with no ties to an extract maker, giving 600 mg a day for 12 weeks and reporting total and free blood testosterone against placebo at 0, 8 and 12 weeks, with women analyzed separately. A matching result from a second independent group would raise certainty from low to moderate.

How this page was made

The 6 sources are four randomized trials and one review found by searching PubMed, plus the NCCIH fact sheet. Ledger studies of ashwagandha on sleep, anxiety and side effects were left out. Every claim was copied word for word into the Longevity Circle ledger and checked against the original text, and a person approved each one. "Contested" means independent trials point in both directions; certainty follows the GRADE levels used in medical reviews. Drafting was assisted by AI.

Changelog: 23 Sep 2026, first version, 6 sources.